Skyhawk Therapeutics’ investigational oral treatment SKY-0515 showed a 1.59-point difference [...]

A US National Institutes of Health grant will fund an [...]

Amyl Therapeutics has raised €8.25m to generate preclinical data for [...]

AC Immune has received FDA Fast Track designation and IND [...]

Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

AstronauTx has exercised its option to acquire worldwide rights to [...]

BioVie has reported topline results from a Phase 2 trial [...]

AC Immune has outlined a series of clinical milestones expected [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]